Home Healthcare Healthcare Services Cell & Gene Therapy Clinical Trials Market

Cell & Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (Oncology, Cardiology, Musculoskeletal, Infectious Diseases, Dermatology, Immunology & Inflammation, Opthalmology, Hematology, Gastroenterology, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 11, 2025 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Cell & Gene Therapy Clinical Trials Market, By Phase 2022-2034 (USD MILLION/ Units)
    1. Phase I
    2. Phase II
    3. Phase III
    4. Phase IV
  2. Cell & Gene Therapy Clinical Trials Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Cardiology
    3. Musculoskeletal
    4. Infectious Diseases
    5. Dermatology
    6. Immunology & Inflammation
    7. Opthalmology
    8. Hematology
    9. Gastroenterology
    10. Others
  3. Regional Cell & Gene Therapy Clinical Trials Market
    1. North America
      1. North America Cell & Gene Therapy Clinical Trials Market By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. North America Cell & Gene Therapy Clinical Trials Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiology
        3. Musculoskeletal
        4. Infectious Diseases
        5. Dermatology
        6. Immunology & Inflammation
        7. Opthalmology
        8. Hematology
        9. Gastroenterology
        10. Others
      3. U.S.
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      4. Canada
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
    2. Europe
      1. Europe Cell & Gene Therapy Clinical Trials Market By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Europe Cell & Gene Therapy Clinical Trials Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiology
        3. Musculoskeletal
        4. Infectious Diseases
        5. Dermatology
        6. Immunology & Inflammation
        7. Opthalmology
        8. Hematology
        9. Gastroenterology
        10. Others
      3. U.K.
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      4. Germany
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      5. France
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      6. Spain
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      7. Italy
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      8. Russia
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      9. Nordic
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      10. Benelux
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      11. Rest of Europe
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
    3. APAC
      1. APAC Cell & Gene Therapy Clinical Trials Market By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. APAC Cell & Gene Therapy Clinical Trials Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiology
        3. Musculoskeletal
        4. Infectious Diseases
        5. Dermatology
        6. Immunology & Inflammation
        7. Opthalmology
        8. Hematology
        9. Gastroenterology
        10. Others
      3. China
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      4. Korea
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      5. Japan
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      6. India
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      7. Australia
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      8. Taiwan
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      9. South East Asia
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      10. Rest of Asia-Pacific
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
    4. Middle East and Africa
      1. Middle East and Africa Cell & Gene Therapy Clinical Trials Market By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. Middle East and Africa Cell & Gene Therapy Clinical Trials Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiology
        3. Musculoskeletal
        4. Infectious Diseases
        5. Dermatology
        6. Immunology & Inflammation
        7. Opthalmology
        8. Hematology
        9. Gastroenterology
        10. Others
      3. UAE
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      4. Turkey
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      5. Saudi Arabia
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      6. South Africa
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      7. Egypt
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      8. Nigeria
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      9. Rest of MEA
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
    5. LATAM
      1. LATAM Cell & Gene Therapy Clinical Trials Market By Phase 2022-2034 (USD MILLION/ Units)
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
      2. LATAM Cell & Gene Therapy Clinical Trials Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Cardiology
        3. Musculoskeletal
        4. Infectious Diseases
        5. Dermatology
        6. Immunology & Inflammation
        7. Opthalmology
        8. Hematology
        9. Gastroenterology
        10. Others
      3. Brazil
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      4. Mexico
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      5. Argentina
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      6. Chile
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      7. Colombia
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
      8. Rest of LATAM
        1. Phase I
        2. Phase II
        3. Phase III
        4. Phase IV
        5. Oncology
        6. Cardiology
        7. Musculoskeletal
        8. Infectious Diseases
        9. Dermatology
        10. Immunology & Inflammation
        11. Opthalmology
        12. Hematology
        13. Gastroenterology
        14. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.